Read news on PARP inhibitors with our app.
Read more in the app
Targeting a signaling pathway activated by acidic tumor environment restores treatment response to PARP inhibitors in ovarian cancer - EurekAlert!
PAK1 blockade sensitizes ovarian cancer to PARP inhibitors - EurekAlert!
Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel ... - EurekAlert
